Angiotensin II Type 1 Receptor Tachyphylaxis Is Defined by Agonist Residence Time

Several GPCRs (G-protein–coupled receptors) have been reported to exhibit tachyphylaxis, which is an acute loss of functional receptor response after repeated stimuli with an agonist. GPCRs are important clinical targets for a wide range of disorders. Therefore, elucidation of the ligand features th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2022-01, Vol.79 (1), p.115-125
Hauptverfasser: Duarte, Diego A., Parreiras-e-Silva, Lucas T., Oliveira, Eduardo B., Bouvier, Michel, Costa-Neto, Claudio M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 125
container_issue 1
container_start_page 115
container_title Hypertension (Dallas, Tex. 1979)
container_volume 79
creator Duarte, Diego A.
Parreiras-e-Silva, Lucas T.
Oliveira, Eduardo B.
Bouvier, Michel
Costa-Neto, Claudio M.
description Several GPCRs (G-protein–coupled receptors) have been reported to exhibit tachyphylaxis, which is an acute loss of functional receptor response after repeated stimuli with an agonist. GPCRs are important clinical targets for a wide range of disorders. Therefore, elucidation of the ligand features that contribute to receptor tachyphylaxis and signaling events underlying this phenomenon is important for drug discovery and development. In this study, we examined the role of ligand-binding kinetics in the tachyphylaxis of AT1R (angiotensin II type 1 receptor) using bioluminescence resonance energy transfer assays to monitor signaling events under both kinetic and equilibrium conditions. We investigated AT1R signal transduction and translocation promoted by the endogenous tachyphylactic agonist Ang II (angiotensin II) and its analogs, described previously for inducing reduced receptor tachyphylaxis. Estimation of binding kinetic parameters of the ligands revealed that the residence time of Ang II was higher than that of the analogs, resulting in more sustained Gq protein activation and recruitment of β-arrestin than that promoted by the analogs. Furthermore, we observed that Ang II led to more sustained internalization of the receptor, thereby retarding its recycling to the plasma membrane and preventing further receptor responses. These results show that the apparent lack of tachyphylaxis in the studied analogs resulted from their short residence time at the AT1R. In addition, our data highlight the relevance of complete characterization of novel GPCR drug candidates, taking into account their receptor binding kinetics as well.
doi_str_mv 10.1161/HYPERTENSIONAHA.121.17977
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2594297062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2594297062</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4136-904206e7bd709cfd4486a08cad6e70c7f0c1722fa2b8c8408cb5ea5ff5a939753</originalsourceid><addsrcrecordid>eNpdkMFu1DAQQC0EotvCLyBz45LF4zh2fIzKwkaqWtoGCU6W40y6hmwS4qxK_r6m23JgpNHI4zdj6xHyHtgaQMLH7Y-vm5tqc3lbXl0W22INHNagtFIvyAoyLhKRyfQlWTHQItEA30_IaQg_GQMhhHpNTlKhUq1kviLXRX_nhxn74HtalrRaRqRAb9DhOA8TrazbLeNu6ewfH2gZ6CdsfY8NrRda3A29D3OEg2-wd0grv8c35FVru4Bvn-oZ-fZ5U51vk4urL-V5cZE4AalMNBOcSVR1o5h2bSNELi3LnW1ikznVMgeK89byOne5iDd1hjZr28zq-PcsPSMfjnvHafh9wDCbvQ8Ou872OByC4ZkWXCsmeUT1EXXTEMKErRknv7fTYoCZv0bNf0ZNNGoejcbZd0_PHOo9Nv8mnxVGQByB-6GbcQq_usM9TmaHtpt3hsUQXOYJZ5wziKckJsj0AURNgrU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2594297062</pqid></control><display><type>article</type><title>Angiotensin II Type 1 Receptor Tachyphylaxis Is Defined by Agonist Residence Time</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><source>American Heart Association</source><creator>Duarte, Diego A. ; Parreiras-e-Silva, Lucas T. ; Oliveira, Eduardo B. ; Bouvier, Michel ; Costa-Neto, Claudio M.</creator><creatorcontrib>Duarte, Diego A. ; Parreiras-e-Silva, Lucas T. ; Oliveira, Eduardo B. ; Bouvier, Michel ; Costa-Neto, Claudio M.</creatorcontrib><description>Several GPCRs (G-protein–coupled receptors) have been reported to exhibit tachyphylaxis, which is an acute loss of functional receptor response after repeated stimuli with an agonist. GPCRs are important clinical targets for a wide range of disorders. Therefore, elucidation of the ligand features that contribute to receptor tachyphylaxis and signaling events underlying this phenomenon is important for drug discovery and development. In this study, we examined the role of ligand-binding kinetics in the tachyphylaxis of AT1R (angiotensin II type 1 receptor) using bioluminescence resonance energy transfer assays to monitor signaling events under both kinetic and equilibrium conditions. We investigated AT1R signal transduction and translocation promoted by the endogenous tachyphylactic agonist Ang II (angiotensin II) and its analogs, described previously for inducing reduced receptor tachyphylaxis. Estimation of binding kinetic parameters of the ligands revealed that the residence time of Ang II was higher than that of the analogs, resulting in more sustained Gq protein activation and recruitment of β-arrestin than that promoted by the analogs. Furthermore, we observed that Ang II led to more sustained internalization of the receptor, thereby retarding its recycling to the plasma membrane and preventing further receptor responses. These results show that the apparent lack of tachyphylaxis in the studied analogs resulted from their short residence time at the AT1R. In addition, our data highlight the relevance of complete characterization of novel GPCR drug candidates, taking into account their receptor binding kinetics as well.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.121.17977</identifier><identifier>PMID: 34739768</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Angiotensin II - pharmacology ; Angiotensin II Type 1 Receptor Blockers - pharmacology ; Cell Membrane - drug effects ; Cell Membrane - metabolism ; HEK293 Cells ; Humans ; Losartan - pharmacology ; Protein Binding ; Receptor, Angiotensin, Type 1 - metabolism ; Signal Transduction - drug effects ; Signal Transduction - physiology ; Tachyphylaxis - physiology</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2022-01, Vol.79 (1), p.115-125</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4136-904206e7bd709cfd4486a08cad6e70c7f0c1722fa2b8c8408cb5ea5ff5a939753</citedby><cites>FETCH-LOGICAL-c4136-904206e7bd709cfd4486a08cad6e70c7f0c1722fa2b8c8408cb5ea5ff5a939753</cites><orcidid>0000-0003-1958-1020 ; 0000-0002-5643-2713 ; 0000-0002-7256-6412</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34739768$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duarte, Diego A.</creatorcontrib><creatorcontrib>Parreiras-e-Silva, Lucas T.</creatorcontrib><creatorcontrib>Oliveira, Eduardo B.</creatorcontrib><creatorcontrib>Bouvier, Michel</creatorcontrib><creatorcontrib>Costa-Neto, Claudio M.</creatorcontrib><title>Angiotensin II Type 1 Receptor Tachyphylaxis Is Defined by Agonist Residence Time</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Several GPCRs (G-protein–coupled receptors) have been reported to exhibit tachyphylaxis, which is an acute loss of functional receptor response after repeated stimuli with an agonist. GPCRs are important clinical targets for a wide range of disorders. Therefore, elucidation of the ligand features that contribute to receptor tachyphylaxis and signaling events underlying this phenomenon is important for drug discovery and development. In this study, we examined the role of ligand-binding kinetics in the tachyphylaxis of AT1R (angiotensin II type 1 receptor) using bioluminescence resonance energy transfer assays to monitor signaling events under both kinetic and equilibrium conditions. We investigated AT1R signal transduction and translocation promoted by the endogenous tachyphylactic agonist Ang II (angiotensin II) and its analogs, described previously for inducing reduced receptor tachyphylaxis. Estimation of binding kinetic parameters of the ligands revealed that the residence time of Ang II was higher than that of the analogs, resulting in more sustained Gq protein activation and recruitment of β-arrestin than that promoted by the analogs. Furthermore, we observed that Ang II led to more sustained internalization of the receptor, thereby retarding its recycling to the plasma membrane and preventing further receptor responses. These results show that the apparent lack of tachyphylaxis in the studied analogs resulted from their short residence time at the AT1R. In addition, our data highlight the relevance of complete characterization of novel GPCR drug candidates, taking into account their receptor binding kinetics as well.</description><subject>Angiotensin II - pharmacology</subject><subject>Angiotensin II Type 1 Receptor Blockers - pharmacology</subject><subject>Cell Membrane - drug effects</subject><subject>Cell Membrane - metabolism</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Losartan - pharmacology</subject><subject>Protein Binding</subject><subject>Receptor, Angiotensin, Type 1 - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><subject>Tachyphylaxis - physiology</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkMFu1DAQQC0EotvCLyBz45LF4zh2fIzKwkaqWtoGCU6W40y6hmwS4qxK_r6m23JgpNHI4zdj6xHyHtgaQMLH7Y-vm5tqc3lbXl0W22INHNagtFIvyAoyLhKRyfQlWTHQItEA30_IaQg_GQMhhHpNTlKhUq1kviLXRX_nhxn74HtalrRaRqRAb9DhOA8TrazbLeNu6ewfH2gZ6CdsfY8NrRda3A29D3OEg2-wd0grv8c35FVru4Bvn-oZ-fZ5U51vk4urL-V5cZE4AalMNBOcSVR1o5h2bSNELi3LnW1ikznVMgeK89byOne5iDd1hjZr28zq-PcsPSMfjnvHafh9wDCbvQ8Ou872OByC4ZkWXCsmeUT1EXXTEMKErRknv7fTYoCZv0bNf0ZNNGoejcbZd0_PHOo9Nv8mnxVGQByB-6GbcQq_usM9TmaHtpt3hsUQXOYJZ5wziKckJsj0AURNgrU</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Duarte, Diego A.</creator><creator>Parreiras-e-Silva, Lucas T.</creator><creator>Oliveira, Eduardo B.</creator><creator>Bouvier, Michel</creator><creator>Costa-Neto, Claudio M.</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1958-1020</orcidid><orcidid>https://orcid.org/0000-0002-5643-2713</orcidid><orcidid>https://orcid.org/0000-0002-7256-6412</orcidid></search><sort><creationdate>20220101</creationdate><title>Angiotensin II Type 1 Receptor Tachyphylaxis Is Defined by Agonist Residence Time</title><author>Duarte, Diego A. ; Parreiras-e-Silva, Lucas T. ; Oliveira, Eduardo B. ; Bouvier, Michel ; Costa-Neto, Claudio M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4136-904206e7bd709cfd4486a08cad6e70c7f0c1722fa2b8c8408cb5ea5ff5a939753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Angiotensin II - pharmacology</topic><topic>Angiotensin II Type 1 Receptor Blockers - pharmacology</topic><topic>Cell Membrane - drug effects</topic><topic>Cell Membrane - metabolism</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Losartan - pharmacology</topic><topic>Protein Binding</topic><topic>Receptor, Angiotensin, Type 1 - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><topic>Tachyphylaxis - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duarte, Diego A.</creatorcontrib><creatorcontrib>Parreiras-e-Silva, Lucas T.</creatorcontrib><creatorcontrib>Oliveira, Eduardo B.</creatorcontrib><creatorcontrib>Bouvier, Michel</creatorcontrib><creatorcontrib>Costa-Neto, Claudio M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duarte, Diego A.</au><au>Parreiras-e-Silva, Lucas T.</au><au>Oliveira, Eduardo B.</au><au>Bouvier, Michel</au><au>Costa-Neto, Claudio M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin II Type 1 Receptor Tachyphylaxis Is Defined by Agonist Residence Time</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>79</volume><issue>1</issue><spage>115</spage><epage>125</epage><pages>115-125</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><abstract>Several GPCRs (G-protein–coupled receptors) have been reported to exhibit tachyphylaxis, which is an acute loss of functional receptor response after repeated stimuli with an agonist. GPCRs are important clinical targets for a wide range of disorders. Therefore, elucidation of the ligand features that contribute to receptor tachyphylaxis and signaling events underlying this phenomenon is important for drug discovery and development. In this study, we examined the role of ligand-binding kinetics in the tachyphylaxis of AT1R (angiotensin II type 1 receptor) using bioluminescence resonance energy transfer assays to monitor signaling events under both kinetic and equilibrium conditions. We investigated AT1R signal transduction and translocation promoted by the endogenous tachyphylactic agonist Ang II (angiotensin II) and its analogs, described previously for inducing reduced receptor tachyphylaxis. Estimation of binding kinetic parameters of the ligands revealed that the residence time of Ang II was higher than that of the analogs, resulting in more sustained Gq protein activation and recruitment of β-arrestin than that promoted by the analogs. Furthermore, we observed that Ang II led to more sustained internalization of the receptor, thereby retarding its recycling to the plasma membrane and preventing further receptor responses. These results show that the apparent lack of tachyphylaxis in the studied analogs resulted from their short residence time at the AT1R. In addition, our data highlight the relevance of complete characterization of novel GPCR drug candidates, taking into account their receptor binding kinetics as well.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>34739768</pmid><doi>10.1161/HYPERTENSIONAHA.121.17977</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-1958-1020</orcidid><orcidid>https://orcid.org/0000-0002-5643-2713</orcidid><orcidid>https://orcid.org/0000-0002-7256-6412</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2022-01, Vol.79 (1), p.115-125
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_miscellaneous_2594297062
source MEDLINE; EZB Electronic Journals Library; American Heart Association
subjects Angiotensin II - pharmacology
Angiotensin II Type 1 Receptor Blockers - pharmacology
Cell Membrane - drug effects
Cell Membrane - metabolism
HEK293 Cells
Humans
Losartan - pharmacology
Protein Binding
Receptor, Angiotensin, Type 1 - metabolism
Signal Transduction - drug effects
Signal Transduction - physiology
Tachyphylaxis - physiology
title Angiotensin II Type 1 Receptor Tachyphylaxis Is Defined by Agonist Residence Time
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T18%3A45%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin%20II%20Type%201%20Receptor%20Tachyphylaxis%20Is%20Defined%20by%20Agonist%20Residence%20Time&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Duarte,%20Diego%20A.&rft.date=2022-01-01&rft.volume=79&rft.issue=1&rft.spage=115&rft.epage=125&rft.pages=115-125&rft.issn=0194-911X&rft.eissn=1524-4563&rft_id=info:doi/10.1161/HYPERTENSIONAHA.121.17977&rft_dat=%3Cproquest_cross%3E2594297062%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2594297062&rft_id=info:pmid/34739768&rfr_iscdi=true